These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22704870)

  • 1. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra).
    Vassilopoulos D; Lazaros G; Tsioufis C; Vasileiou P; Stefanadis C; Pectasides D
    Int J Cardiol; 2012 Sep; 160(1):66-8. PubMed ID: 22704870
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
    Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
    Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases.
    Lazaros G; Vasileiou P; Koutsianas C; Antonatou K; Stefanadis C; Pectasides D; Vassilopoulos D
    Ann Rheum Dis; 2014 Dec; 73(12):2215-7. PubMed ID: 25165036
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
    Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
    Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant or recurrent acute pericarditis: a new therapeutic opportunity?
    Massardier C; Dauphin C; Eschalier R; Lusson JR; Soubrier M
    Int J Cardiol; 2014 Dec; 177(2):e75-7. PubMed ID: 25449496
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenetic mechanisms, new drugs, and old problems in idiopathic recurrent pericarditis: comment on the article by Picco et al.
    Brucato A; Imazio M; Spodick D; Adler Y
    Arthritis Rheum; 2009 Aug; 60(8):2543; author reply 2543-4. PubMed ID: 19644862
    [No Abstract]   [Full Text] [Related]  

  • 7. Idiopathic relapsing acute pericarditis: Report of one case with favorable response to anakinra.
    Roque Rojas F; Mellor Pita S; Tutor de Ureta P
    Med Clin (Barc); 2018 Feb; 150(4):160. PubMed ID: 28919212
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment.
    Cantarini L; Lucherini OM; Cimaz R; Galeazzi M
    Clin Exp Rheumatol; 2010; 28(5):802. PubMed ID: 21029567
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of an interleukin-1β receptor antagonist (anakinra) in idiopathic recurrent pericarditis.
    Scardapane A; Brucato A; Chiarelli F; Breda L
    Pediatr Cardiol; 2013; 34(8):1989-91. PubMed ID: 23052671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of anakinra for idiopathic and non-idiopathic pericarditis refractory or intolerant to conventional therapy.
    Shaukat MH; Singh S; Davis K; Torosoff M; Peredo-Wende R
    Eur Heart J Acute Cardiovasc Care; 2020 Dec; 9(8):888-892. PubMed ID: 32159368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 inhibition with anakinra in a patient with refractory gout.
    Singh D; Huston KK
    J Clin Rheumatol; 2009 Oct; 15(7):366. PubMed ID: 20009976
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel therapy for an unusual problem: IL-1 receptor antagonist for recurrent post-transplant pericarditis.
    Parizo JT; Moayedi Y; Nieman K; Town K; Teuteberg JJ; Khush KK
    Clin Transplant; 2019 Oct; 33(10):e13699. PubMed ID: 31437316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of anakinra in a case of refractory Still disease.
    Debiais S; Maillot F; Luca L; Buret J; Fautrel B; Renard JP
    J Clin Rheumatol; 2008 Dec; 14(6):357-8. PubMed ID: 19033875
    [No Abstract]   [Full Text] [Related]  

  • 14. The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis.
    Swart JF; Barug D; Möhlmann M; Wulffraat NM
    Expert Opin Biol Ther; 2010 Dec; 10(12):1743-52. PubMed ID: 20979564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anakinra During Pregnancy in a Difficult to Treat Case of Recurrent Pericarditis.
    Negro E; Costedoat-Chalumeau N; Nivuori M; Gabiati C; Pallini G; Brucato A
    Can J Cardiol; 2023 Aug; 39(8):1152-1153. PubMed ID: 36306922
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
    Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients.
    Dagan A; Langevitz P; Shoenfeld Y; Shovman O
    Autoimmun Rev; 2019 Jun; 18(6):627-631. PubMed ID: 30959216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subacute liver failure following anakinra treatment for adult-onset Still disease.
    Aly L; Iking-Konert C; Quaas A; Benten D
    J Rheumatol; 2013 Oct; 40(10):1775-7. PubMed ID: 24085761
    [No Abstract]   [Full Text] [Related]  

  • 19. Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report.
    Karadeniz H; Yamak BA; Özger HS; Sezenöz B; Tufan A; Emmi G
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):883-885. PubMed ID: 32734502
    [No Abstract]   [Full Text] [Related]  

  • 20. Anakinra in Recurrent Pericarditis: Current Evidence on Clinical Use, Effectiveness, and Safety.
    Correia ETO; Dos Santos Barbetta LM; de Almeida JPCL; Mesquita ET
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):42-49. PubMed ID: 32265370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.